NewAmsterdam Pharma Company NV Ordinary Shares

Price & Volume

Stats

52W Range	$15.19-$27.29
Market Cap	$2.2B
Shares Short	2M

Financials

Revenue (12 Mos)	$33.5M
Revenue Growth (YoY)	889.8%
Gross Profit (12 Mos)	$0
Diluted EPS	-$2.21

News

Yahoo Finance • 16 days ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance • 7 months ago

NewAmsterdam Pharma Second Quarter 2024 Earnings: Beats Expectations

Yahoo Finance • 10 months ago

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

Yahoo Finance • 11 months ago

NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease

About

CEO	Dr. Michael Harvey Davidson FACC, Facp., M.D.
Address	Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	62